164 related articles for article (PubMed ID: 29244229)
1. Transoral robotic surgery for residual and recurrent oropharyngeal cancers: Exploratory study of surgical innovation using the IDEAL framework for early-phase surgical studies.
Paleri V; Fox H; Coward S; Ragbir M; McQueen A; Ahmed O; Meikle D; Saleh D; O'Hara J; Robinson M
Head Neck; 2018 Mar; 40(3):512-525. PubMed ID: 29244229
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of transoral laser microsurgery and transoral robotic surgery in oropharyngeal squamous cell carcinoma.
Sievert M; Goncalves M; Zbidat A; Traxdorf M; Mueller SK; Iro H; Gostian AO
Auris Nasus Larynx; 2021 Apr; 48(2):295-301. PubMed ID: 32883577
[TBL] [Abstract][Full Text] [Related]
3. Transoral Robotic Surgery for Residual and Recurrent Oropharyngeal Cancers.
Paleri V; Hardman J; Brady G; George A; Kerawala C
Otolaryngol Clin North Am; 2020 Dec; 53(6):1091-1108. PubMed ID: 33127041
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of Free Flap Reconstruction Following Salvage Robotic-Assisted Resection of Recurrent and Residual Oropharyngeal Cancer in 3 Patients.
Williamson A; Haywood M; Awad Z
Ear Nose Throat J; 2021 Dec; 100(10_suppl):1113S-1118S. PubMed ID: 32608257
[TBL] [Abstract][Full Text] [Related]
5. Functional outcomes, feasibility, and safety of resection of transoral robotic surgery: single-institution series of 35 consecutive cases of transoral robotic surgery for oropharyngeal squamous cell carcinoma.
Lörincz BB; Möckelmann N; Busch CJ; Knecht R
Head Neck; 2015 Nov; 37(11):1618-24. PubMed ID: 24955923
[TBL] [Abstract][Full Text] [Related]
6. Salvage surgery for recurrent cancers of the oropharynx: comparing TORS with standard open surgical approaches.
White H; Ford S; Bush B; Holsinger FC; Moore E; Ghanem T; Carroll W; Rosenthal E; Sweeny L; Magnuson JS
JAMA Otolaryngol Head Neck Surg; 2013 Aug; 139(8):773-8. PubMed ID: 23949352
[TBL] [Abstract][Full Text] [Related]
7. Transoral robotic surgery for oropharyngeal carcinoma: Surgical margins and oncologic outcomes.
Moore EJ; Van Abel KM; Price DL; Lohse CM; Olsen KD; Jackson RS; Martin EJ
Head Neck; 2018 Apr; 40(4):747-755. PubMed ID: 29327784
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and safety of transoral robotic surgery (TORS) for early hypopharyngeal cancer: a subset analysis of the Hamburg University TORS-trial.
Lörincz BB; Busch CJ; Möckelmann N; Knecht R
Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):2993-8. PubMed ID: 25217079
[TBL] [Abstract][Full Text] [Related]
9. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ
Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038
[TBL] [Abstract][Full Text] [Related]
10. Comparative safety and effectiveness of transoral robotic surgery versus open surgery for oropharyngeal cancer: A systematic review and meta-analysis.
Park DA; Lee MJ; Kim SH; Lee SH
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):644-649. PubMed ID: 31627931
[TBL] [Abstract][Full Text] [Related]
11. Transoral Robotic Surgery for Oropharyngeal Cancer.
Paleri V; Fox H; Winter S
ORL J Otorhinolaryngol Relat Spec; 2018; 80(3-4):156-170. PubMed ID: 30016769
[TBL] [Abstract][Full Text] [Related]
12. Oncological outcome following de-intensification of treatment for stage I and II HPV negative oropharyngeal cancers with transoral robotic surgery (TORS): A prospective trial.
Dabas S; Gupta K; Ranjan R; Sharma AK; Shukla H; Dinesh A
Oral Oncol; 2017 Jun; 69():80-83. PubMed ID: 28559025
[TBL] [Abstract][Full Text] [Related]
13. Outcome of transoral robotic surgery for stage I-II oropharyngeal cancer.
van Loon JW; Smeele LE; Hilgers FJ; van den Brekel MW
Eur Arch Otorhinolaryngol; 2015 Jan; 272(1):175-83. PubMed ID: 24609641
[TBL] [Abstract][Full Text] [Related]
14. The impact of socioeconomic and geographic factors on access to transoral robotic/endoscopic surgery for early stage oropharyngeal malignancy.
Groysman M; Yi SK; Robbins JR; Hsu CC; Julian R; Bauman JE; Baker A; Wang SJ; Bearelly S
Am J Otolaryngol; 2022; 43(1):103243. PubMed ID: 34583290
[TBL] [Abstract][Full Text] [Related]
15. Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption.
Li H; Torabi SJ; Park HS; Yarbrough WG; Mehra S; Choi R; Judson BL
Laryngoscope; 2019 Aug; 129(8):1844-1855. PubMed ID: 30575965
[TBL] [Abstract][Full Text] [Related]
16. Cervical-transoral robotic oropharyngectomy and thin anterolateral thigh free flap.
Gorphe P; Temam S; Kolb F; Qassemyar Q
Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Feb; 135(1):71-74. PubMed ID: 28927845
[TBL] [Abstract][Full Text] [Related]
17. Decreased gastrostomy tube incidence and weight loss after transoral robotic surgery for low- to intermediate-risk oropharyngeal squamous cell carcinoma.
Heah H; Goepfert RP; Hutcheson KA; Garden AS; Gunn GB; Fuller CD; Lewin JS; Kupferman ME; Holsinger FC; Hessel AC; Gross ND
Head Neck; 2018 Nov; 40(11):2507-2513. PubMed ID: 30102824
[TBL] [Abstract][Full Text] [Related]
18. Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma.
Sinclair CF; McColloch NL; Carroll WR; Rosenthal EL; Desmond RA; Magnuson JS
Arch Otolaryngol Head Neck Surg; 2011 Nov; 137(11):1112-6. PubMed ID: 22106235
[TBL] [Abstract][Full Text] [Related]
19. Transoral surgery (TOS) in oropharyngeal cancer: Different tools, a single mini-invasive philosophy.
Tirelli G; Boscolo Nata F; Piovesana M; Quatela E; Gardenal N; Hayden RE
Surg Oncol; 2018 Dec; 27(4):643-649. PubMed ID: 30449487
[TBL] [Abstract][Full Text] [Related]
20. What should we expect from robotic surgery for second primary oropharyngeal cancer?
Fang TJ; Lee LA; Huang BS; Lin CY; Hsu CL; Chang JT; Yen TC; Liao CT; Chiang HC
Eur Arch Otorhinolaryngol; 2017 Aug; 274(8):3161-3168. PubMed ID: 28484837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
